What Is the Prognostic Value of a Zero Calcium Score?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.  by Redberg, Rita F.
W
P
a
R
S
D
h
T
d
c
F
g
s
A
c
a
g
c
a
c
s
c
F
s
w
b
s
a
t
o
a
t
f
C
n
v
s
c
D
i
p
c
s
p
1
s
C
a
6
c
c
t
s
e
2
P
a
C
i
G
s
a
m
C
a
s
I
i
a
i
d
t
s
y
m
t
a
e
s
h
s
f
m
*
v
A
F
Journal of the American College of Cardiology Vol. 55, No. 7, 2010
© 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00
Published by Elsevier Inc. doi:10.1016/j.jacc.2009.08.076EDITORIAL COMMENT
hat Is the
rognostic Value of
Zero Calcium Score?*
ita F. Redberg, MD
an Francisco, California
espite remarkable advances in knowledge and technology,
eart disease remains the leading cause of death in the U.S.
hus, the search continues for more effective ways to
iagnose heart disease early, and hopefully prevent more
ardiac deaths. More than 30 years ago, Diamond and
orrester (1) presented a method for predicting angio-
raphic disease based on age, sex, and type of chest pain
ymptoms. To this day, American College of Cardiology/
merican Heart Association guidelines essentially use this
linical assessment to determine the probability of coronary
rtery disease (CAD). For patients whose assessment sug-
ests an intermediate probability for CAD, clinicians typi-
ally recommend some type of stress test. Patients with
bnormal stress tests then are often referred for invasive
oronary angiography (ICA).
See page 627
As stress tests may not be scheduled easily in a triage
etting, other tests have been proposed as faster and more
onvenient ways to decide who should be referred for ICA.
or example, coronary artery calcium scoring (CS) has been
uggested as a noninvasive test that can risk-stratify patients
ith chest pain and reliably identify candidates who may
enefit from ICA. In support of this approach, a recent
ystematic review of CS studies of both symptomatic and
symptomatic populations led investigators to conclude that
he absence of coronary calcification was a reliable predictor
f the absence of angiographic CAD (2,3). Sarwar et al. (2)
rgued, therefore, that patients without coronary calcifica-
ion are highly unlikely to have CAD and do not need
urther testing. Their review of 18 studies of the accuracy of
S for predicting CAD in symptomatic patients found a
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.c
From the Department of Cardiology, University of California San Francisco, San
rancisco, California.egative predictive value of 93% and a positive predictive
alue of 68% (2).
A paper in this issue of the Journal, however, presents a
tarkly contrasting picture. In a substudy of their multi-
enter CORE64 (Coronary Evaluation Using Multi-
etector Spiral Computed Tomography Angiography Us-
ng 64 Detectors) trial, Gottlieb et al. (4) analyzed 291
atients (73% men, average age 59 years) who, as part of a
hest pain workup, underwent a coronary artery calcium
can followed by coronary angiography. Moreover, of the
atients who had a CS of 0 (24% of the total population),
9% were found to have significant CAD (at least 1 50%
tenosis by angiography)—that is, nearly 1 in 5 patients had
AD that the CS failed to predict. Statistically, Gottlieb et
l. (4) calculated a lower negative predictive value of CS of
8%, and a positive predictive value of 81%, leading them to
onclude that a CS 0 does not reliably rule out significant
oronary disease, and to caution against use of the CS for
his purpose.
So why the apparent discrepancies between the earlier
ystematic reviews and the current clinical trial by Gottlieb
t al. (4)? Possibly, there were different characteristics in the
populations studied—age, sex, and cardiac risk factors.
re-test probability of disease, for example, can substantially
ffect analysis of the clinical utility of a diagnostic test. The
ORE64 study CS subgroup had more men than reported
n the systematic review (73% vs. 60% men). However, both
ottlieb et al. (4) and Sarwar et al. (2) reported the exact
ame prevalence of obstructive coronary artery disease by
ngiography: 56% in their populations.
Although CS and ICA are both anatomic tests, they
easure different stages of the atherosclerotic process.
oronary calcification is thought to occur late in the
therosclerotic pathway (and may be a marker for plaque
tability), whereas obstructive atherosclerotic disease seen by
CA may not be directly associated with calcification. Thus,
t is not surprising that significant CAD can occur in the
bsence of calcification.
For the clinician, any new diagnostic test poses the critical
ssue of “what information will I learn from this test that I
idn’t already know, and how will this additional informa-
ion lead to improved care of this patient?” Gottlieb et al. (4)
uggest that the benefit of a CS for risk stratification is not
et proven. Neither Gottlieb nor Sarwar give us any infor-
ation on how the CS adds incremental information to the
raditional predictors for CAD, such as clinical assessment
nd stress testing.
This apparent lack of predictive value of a CS should be
nough to give a clinician pause. When combined with the
ignificant radiation risks of coronary artery calcium scans,
owever, clinicians must use extreme caution when ordering
uch scans. Indeed, recent data show that the cancer risk
rom a single coronary artery calcium test at age 40 years
ay be as many as 9 cancers per 100,000 men and 28
ancers per 100,000 women (5). Gibbons and Gerber (6)
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Prognostic Value of a Zero Calcium Score February 16, 2010:635–6rgue that we must consider the cancer risk when ordering
oronary artery calcium scans (or any other nuclear test), and
hat providers must discuss both risks and benefits with the
atient. Radiation risks are even higher when the CS is used
n addition to other testing for ischemia such as myocardial
erfusion imaging.
In any event, the findings by Gottlieb et al. (4) squarely
aise a key question: what is the added value of a CS? In
articular, does a CS add, even incrementally, to the
redictive value for CAD established 30 years ago based
imply on demographics and type of chest pain? This
uestion cannot be answered precisely, because the studies
f the CS as a predictor of CAD or cardiac events have not
nalyzed the incremental risk prediction over clinical assess-
ent. However, the conflicting results from Gottlieb et al.
4) and Sarwar et al. (2) suggest that more data, from
opulations of varying pre-test probability of CAD with
ngiographic and meaningful clinical end points such as
onfatal myocardial infarction and cardiac death, are needed
o answer this question. Until then, a CS of 0 cannot be
nterpreted as a reassurance of the absence of CAD. The
ndings by Gottlieb et al. (4) reinforce the importance of
omparing new diagnostic tests to more traditional clinical
redictors, especially when the tests expose patients to
nown risks but uncertain benefits. The CS, in particular,
ay yet have its place in the clinician’s arsenal for evaluation tf patients with chest pain, but until its benefits are clearly
stablished, we must take great care when subjecting pa-
ients to it.
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